Table 1 The seroprevalence of LASV GP and NP binding antibody (IgG and IgM) response among survivors and their contacts in Southern Nigeria.
Sub-population | NP-IgG (%) | PF-GP-IgG (%) | NP-IgM (%) | PF-GP-IgM (%) |
---|---|---|---|---|
LF survivors | 77 | 48 | 32 | 23 |
Contacts | 64 | 50 | 48 | 33 |